Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
about
Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years.Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48.Detection of Active Sacroiliitis with Ankylosing Spondylitis through Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging.First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?Diagnostics of Sacroiliitis According to ASAS Criteria: A Comparative Evaluation of Conventional Radiographs and MRI in Patients with a Clinical Suspicion of Spondyloarthropathy. Preliminary Results.Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumabUpdated consensus statement on biological agents for the treatment of rheumatic diseases, 2007Pharmacological management of undifferentiated spondyloarthropathies.Early diagnosis of spondyloarthritis.Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis.Tumor necrosis factor as a therapeutic target of rheumatologic disease.Successful etanercept therapy for refractory sacroiliitis in a patient with ankylosing spondylitis and mixed connective tissue disease.Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis.How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis.EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study.The relationship between inflammation and new bone formation in patients with ankylosing spondylitis.Opinion: Perspectives on imaging in axial spondyloarthritis.Adalimumab for the treatment of ankylosing spondylitis.Managing morbidity and treatment-related toxicity in patients with ankylosing spondylitis.MRI for diagnosis of axial spondyloarthritis: major advance with critical limitations 'Not everything that glisters is gold (standard)'.A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool).
P2860
Q33766318-5E327FE4-F76C-42CA-8ADC-D73CAD9BD7F3Q35012163-A36DDAF0-DA08-46F7-B8ED-A6C5DFBAA718Q35560343-FCF90321-0028-473B-9F75-6011B02DCBD7Q35636900-DB3B6093-9BD9-4EFD-9E5F-11C621828E7FQ35638233-DD83B11F-C443-47CC-9D75-2A132AD85DD0Q35648115-1B818E1C-177C-48BB-8135-61C89A2F6224Q35759171-66DFEF0C-5FEB-4AD7-BDD3-0DD57F388DA5Q36171750-B6621B2C-7A0E-4288-9377-C84C9BFC225BQ36349645-77EB6E9D-4C19-40B4-913E-18FA73A81571Q36611042-5670F2D9-3147-49F1-B65A-1193D1F1B15DQ36773202-B15A7C84-C695-49B9-9349-C6E15937D8EFQ37008829-D17056D7-B0E3-4E07-A20E-4C85520DF437Q37040863-92735B8F-A747-4119-97E8-9358732F4C33Q37172795-A5E335B5-2044-4275-9F03-D59296FA3B83Q37215981-1CFE819D-417F-4D82-9263-8A6D6EB24F26Q38120525-46C49331-1559-47D1-B223-5071F2A17BAEQ38402703-10EA2E1B-4F51-492B-9F64-D3D5AFA1F4B1Q38762450-291AA044-7D7F-451F-AEC0-1286BABE3F9EQ41396084-32294D11-8B5A-4659-9D3F-35F8BA6D5674Q42604065-116D0E66-6A90-4682-86B3-B90E83F287CFQ42616837-E82DCBD1-583D-4882-8422-2F7987E652F8Q48641283-792FC679-0F2D-4236-A54A-7AA8B11CDF02Q50300113-D4E9E932-FD22-41DA-A5E9-00E4AFA6FFBAQ51079406-3C8ACA3B-2EF2-43ED-9B7D-DBB72E0707A2
P2860
Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Magnetic resonance imaging of ...... ing treatment with etanercept.
@en
Magnetic resonance imaging of ...... ing treatment with etanercept.
@nl
type
label
Magnetic resonance imaging of ...... ing treatment with etanercept.
@en
Magnetic resonance imaging of ...... ing treatment with etanercept.
@nl
prefLabel
Magnetic resonance imaging of ...... ing treatment with etanercept.
@en
Magnetic resonance imaging of ...... ing treatment with etanercept.
@nl
P2093
P2860
P356
P1476
Magnetic resonance imaging of ...... ing treatment with etanercept.
@en
P2093
P2860
P304
P356
10.1136/ARD.2004.032441
P407
P577
2005-03-18T00:00:00Z